Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Athena Diagnostics | RCV000713081 | SCV000843649 | benign | not provided | 2017-04-20 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000713081 | SCV001720620 | benign | not provided | 2025-02-04 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000713081 | SCV001900433 | benign | not provided | 2019-11-13 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001807318 | SCV002054543 | benign | Developmental and epileptic encephalopathy, 62 | 2021-07-15 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001807317 | SCV002054544 | benign | Epilepsy, familial focal, with variable foci 4 | 2021-07-15 | criteria provided, single submitter | clinical testing | |
Unidad de Genómica Garrahan, |
RCV004594104 | SCV005087389 | benign | not specified | 2024-07-15 | criteria provided, single submitter | clinical testing | This variant is classified as Benign based on local population frequency. This variant was detected in 76% of patients studied in a panel designed for Epileptic and Developmental Encephalopathy and Progressive Myoclonus Epilepsy. Number of patients: 71. Only high quality variants are reported. |
Breakthrough Genomics, |
RCV000713081 | SCV005239571 | benign | not provided | criteria provided, single submitter | not provided |